These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 3920702)

  • 1. Effects of sulpiride and chlorpromazine on autistic and positive psychotic symptoms in schizophrenic patients--relationship to drug concentrations.
    Alfredsson G; Härnryd C; Wiesel FA
    Psychopharmacology (Berl); 1985; 85(1):8-13. PubMed ID: 3920702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of sulpiride and chlorpromazine on depressive symptoms in schizophrenic patients--relationship to drug concentrations.
    Alfredsson G; Härnryd C; Wiesel FA
    Psychopharmacology (Berl); 1984; 84(2):237-41. PubMed ID: 6438683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical evaluation of sulpiride in schizophrenic patients--a double-blind comparison with chlorpromazine.
    Härnryd C; Bjerkenstedt L; Björk K; Gullberg B; Oxenstierna G; Sedvall G; Wiesel FA; Wik G; Aberg-Wistedt A
    Acta Psychiatr Scand Suppl; 1984; 311():7-30. PubMed ID: 6367364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationships between drug concentrations in serum and CSF, clinical effects and monoaminergic variables in schizophrenic patients treated with sulpiride or chlorpromazine.
    Alfredsson G; Bjerkenstedt L; Edman G; Härnryd C; Oxenstierna G; Sedvall G; Wiesel FA
    Acta Psychiatr Scand Suppl; 1984; 311():49-74. PubMed ID: 6199949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships between clinical effects and monoamine metabolites and amino acids in sulpiride-treated schizophrenic patients.
    Alfredsson G; Wiesel FA
    Psychopharmacology (Berl); 1990; 101(3):324-31. PubMed ID: 2362952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of sulpiride and chlorpromazine in psychoses. A double-blind multicentre study.
    Bratfos O; Haug JO
    Acta Psychiatr Scand; 1979 Jul; 60(1):1-9. PubMed ID: 382750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The evaluation of the anti-autistic activity of sulpiride.
    Elizur A; Davidson S
    Curr Ther Res Clin Exp; 1975 Oct; 18(4):578-84. PubMed ID: 810319
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical effects and drug concentrations in plasma and cerebrospinal fluid in psychotic patients treated with fixed doses of chlorpromazine.
    Wode-Helgodt B; Borg S; Fyrö B; Sedvall G
    Acta Psychiatr Scand; 1978 Aug; 58(2):149-73. PubMed ID: 358755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulpiride and haloperidol in schizophrenia: a double-blind cross-over study of therapeutic effect, side effects and plasma concentrations.
    Gerlach J; Behnke K; Heltberg J; Munk-Anderson E; Nielsen H
    Br J Psychiatry; 1985 Sep; 147():283-8. PubMed ID: 3904885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind trial of thiothixene and chlorpromazine in acute schizophrenia.
    Rickels K; Byrdy H; Valentine J; Postel W; Norstad N; Downing R
    Int Pharmacopsychiatry; 1978; 13(1):50-7. PubMed ID: 342437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A clinical and pharmacodynamic evaluation of sulpiride.
    Rao VA; Bailey J; Bishop M; Coppen A
    Psychopharmacology (Berl); 1981; 73(1):77-80. PubMed ID: 6785794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled trial of sulpiride in chronic schizophrenic patients.
    Edwards JG; Alexander JR; Alexander MS; Gordon A; Zutchi T
    Br J Psychiatry; 1980 Dec; 137():522-9. PubMed ID: 7011469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Penfluridol: a long acting oral antipsychotic drug.
    Claghorn JL; Mathew RJ; Mirabi M
    J Clin Psychiatry; 1979 Feb; 40(2):107-9. PubMed ID: 368045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulpiride and perphenazine in schizophrenia. A double-blind clinical trial.
    Lepola U; Koskinen T; Rimón R; Salo H; Gordin A
    Acta Psychiatr Scand; 1989 Jul; 80(1):92-6. PubMed ID: 2669445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Three antipsychotic drugs in the treatment of schizophrenia--a controlled and double-blind study].
    Yang WJ
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1988 Oct; 21(5):277-80, 318-9. PubMed ID: 3069383
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of sulpiride in a case of atypical autism.
    Scott DW; Eames P
    J Autism Dev Disord; 1988 Mar; 18(1):144-6. PubMed ID: 3372456
    [No Abstract]   [Full Text] [Related]  

  • 17. The risks and benefits of clozapine versus chlorpromazine.
    Claghorn J; Honigfeld G; Abuzzahab FS; Wang R; Steinbook R; Tuason V; Klerman G
    J Clin Psychopharmacol; 1987 Dec; 7(6):377-84. PubMed ID: 3323261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ziprasidone and amisulpride effectively treat negative symptoms of schizophrenia: results of a 12-week, double-blind study.
    Olié JP; Spina E; Murray S; Yang R
    Int Clin Psychopharmacol; 2006 May; 21(3):143-51. PubMed ID: 16528136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loxapine: a double-blind comparison with chlorpromazine in acute schizophrenic patients.
    Steinbook RM; Goldstein BJ; Brauzer B; Moreno SS; Jacobson AF
    Curr Ther Res Clin Exp; 1973 Jan; 15(1):1-7. PubMed ID: 4631378
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of butaclamol in chronic schizophrenic patients.
    Clark ML; Paredes A; Costiloe JP; Wood F
    J Clin Pharmacol; 1977; 17(8-9):529-36. PubMed ID: 19510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.